Katja Berlinger
Voorzitter bij Steinhoff Europe AG
Profiel
Katja Berlinger is currently the Chairman-Supervisory Board at Steinhoff Europe AG and a Principal at Berlinger & Co. AG.
Previously, she held positions as a Director at Neurotune AG and Xeltis AG.
She has an MBA from INSEAD and an undergraduate degree from the University of Zurich.
Actieve functies van Katja Berlinger
Bedrijven | Functie | Begin |
---|---|---|
Berlinger & Co. AG
Berlinger & Co. AG Industrial MachineryProducer Manufacturing Berlinger & Co. AG manufactures temperature monitoring devices. It offers temperature monitoring and drug and doping control. The firm serves pharmaceuticals, clinical trials, health sector, chemicals, logistics, food, and charities. The company as founded by Johan Georg Berlinger in 1865 and is headquartered in Ganterschwil, Switzerland. | Corporate Officer/Principal | - |
Steinhoff Europe AG
Steinhoff Europe AG Home FurnishingsConsumer Durables Steinhoff Europe AG manufactures and distributes household goods. The company provides collections for dining rooms, offices, bedrooms, and hotels. It designs and supplies furniture for homes and apartments. Steinhoff Europe is headquartered in Wilen, Switzerland. | Voorzitter | - |
Eerdere bekende functies van Katja Berlinger
Bedrijven | Functie | Einde |
---|---|---|
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Directeur/Bestuurslid | - |
Neurotune AG
Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Directeur/Bestuurslid | - |
Opleiding van Katja Berlinger
INSEAD | Masters Business Admin |
University of Zurich | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Steinhoff Europe AG
Steinhoff Europe AG Home FurnishingsConsumer Durables Steinhoff Europe AG manufactures and distributes household goods. The company provides collections for dining rooms, offices, bedrooms, and hotels. It designs and supplies furniture for homes and apartments. Steinhoff Europe is headquartered in Wilen, Switzerland. | Consumer Durables |
Neurotune AG
Neurotune AG Pharmaceuticals: MajorHealth Technology Neurotune AG develops medications for neuropathic pain and sarcopenia. The firm is developing treatments which modulate the connections between nerve cells and its target cells. The company was founded by Bruno Oesch in January 2005 and is headquartered in Schlieren-Zurich, Switzerland. | Health Technology |
Berlinger & Co. AG
Berlinger & Co. AG Industrial MachineryProducer Manufacturing Berlinger & Co. AG manufactures temperature monitoring devices. It offers temperature monitoring and drug and doping control. The firm serves pharmaceuticals, clinical trials, health sector, chemicals, logistics, food, and charities. The company as founded by Johan Georg Berlinger in 1865 and is headquartered in Ganterschwil, Switzerland. | Producer Manufacturing |
Xeltis AG
Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Health Technology |